申请人:Merck Sharp & Dohme Limited
公开号:US05661162A1
公开(公告)日:1997-08-26
The present invention is directed to compounds of the formula (I) ##STR1## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.5, R.sup.6, R.sup.7, R.sup.8, m, n and X are defined herein, and pharmaceutically acceptable salts thereof, which are useful as tachykinin antagonists.
本发明涉及式(I)的化合物:##STR1## 其中R.sup.1、R.sup.2、R.sup.3、R.sup.5、R.sup.6、R.sup.7、R.sup.8、m、n和X如本文所定义,并且其药学上可接受的盐,其作为快速激动肽拮抗剂有用。